| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44044651 | HTLV-1 | ENSG00000077092.20 | protein_coding | RARB | No | No | 5915 | P10826 Q5QHG3 Q86UC5 |
| TVIS44048782 | HTLV-1 | ENSG00000077092.20 | protein_coding | RARB | No | No | 5915 | P10826 Q5QHG3 Q86UC5 |
| TVIS44036417 | HTLV-1 | ENSG00000077092.20 | protein_coding | RARB | No | No | 5915 | P10826 Q5QHG3 Q86UC5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | RARB |
|---|---|
| DrugBank ID | DB12808 |
| Drug Name | Trifarotene |
| Target ID | BE0000206 |
| UniProt ID | P10826 |
| Regulation Type | agonist |
| PubMed IDs | 29974453 |
| Citations | Aubert J, Piwnica D, Bertino B, Blanchet-Rethore S, Carlavan I, Deret S, Dreno B, Gamboa B, Jomard A, Luzy AP, Mauvais P, Mounier C, Pascau J, Pelisson I, Portal T, Rivier M, Rossio P, Thoreau E, Vial E, Voegel JJ: Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-gamma agonist trifarotene. Br J Dermatol. 2018 Aug;179(2):442-456. doi: 10.1111/bjd.16719. Epub 2018 Jul 4. |
| Groups | Approved; Investigational |
| Direct Classification | M-terphenyls |
| SMILES | CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3707313 |
